MTNB

SEC source: 0000905718-18-000907 · ownership.xml · derivative · entry 2

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000907 · ownership.xml · derivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000908 · ownership.xml · derivative · entry 2

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000908 · ownership.xml · derivative · entry 1

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000909 · ownership.xml · derivative · entry 2

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000909 · ownership.xml · derivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000906 · matinasbiofm4_oct12018.xml · derivative · entry 2

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000906 · matinasbiofm4_oct12018.xml · derivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000910 · ownership.xml · derivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000910 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000853 · matinasbiofm4_oct152018.xml · derivative · entry 1

Matkovits Theresa · CIK 0001745393 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2028-10-15

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests as to 25% on October 25, 2019, and the remaining 75% of the shares will vest in equal monthly installments over the following thirty-six (36) months commencing on November 25, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000821 · matinasbiofm4_oct12018.xml · nonDerivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,069

F1 · shares: On October 1, 2018, the Reporting Person was granted 9,715 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On October 1, 2018, the Reporting Person was granted 9,715 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000823 · matinasbiofm4_oct12018.xml · nonDerivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,975

F1 · price: On October 1, 2018, the Reporting Person was granted 19,294 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000817 · conrad-matinas_fm4jun212018.xml · nonDerivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,992,566

F1 · shares: On October 1, 2018, the Reporting Person was granted 26,087 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equit Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On October 1, 2018, the Reporting Person was granted 26,087 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equit Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000819 · scibetta_form4jun292018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,565

F1 · shares: On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000782 · ownership.xml · derivative · entry 1

LEPORE PATRICK G · CIK 0001055404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-09-05

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on October 5, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000620 · ende-matinas_fm4jun292018.xml · nonDerivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,354

F1 · shares: On June 29, 2018, the Reporting Person was granted 20,594 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On June 29, 2018, the Reporting Person was granted 20,594 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000622 · wikler-matinasfm4_jun292018.xml · nonDerivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,681

F1 · shares: On June 29, 2018, the Reporting Person was granted 32,259 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On June 29, 2018, the Reporting Person was granted 32,259 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000626 · conrad-matinas_fm4jun292018.xml · nonDerivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,966,479

F1 · shares: On June 29, 2018, the Reporting Person was granted 55,300 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On June 29, 2018, the Reporting Person was granted 55,300 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000624 · scibetta_form4jun292018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486,184

F1 · shares: On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000580 · ende-matinas_fm4jun212018.xml · derivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12

Underlying: Common Stock · 24,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000588 · stern_matinas-fm4jun212018.xml · derivative · entry 1

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AKS Family Partners LP

Disclosed balance after: 85

Underlying: Common Stock · 170,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, AKS Family Partners LP purchased 85 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, AKS Family Partners LP purchased 85 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F2 · ownership.nature: Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.

SEC source: 0000905718-18-000586 · wikler-matinasfm4_jun212018.xml · derivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6

Underlying: Common Stock · 12,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased six shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased six shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000590 · mannino-matinasfm4_jun212018.xml · derivative · entry 1

MANNINO RAPHAEL J · CIK 0001196697 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 10 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 10 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000582 · conrad-matinas_fm4jun212018.xml · derivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 100 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 100 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000592 · scibetta_form4jun212018.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12

Underlying: Common Stock · 24,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000584 · jabbour-matinasfm4_jun2118.xml · derivative · entry 1

Jabbour Jerome D · CIK 0001698838 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 15 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 15 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000450 · wiklerfm4_apr302018.xml · derivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-04-29

F1 · derivative.exercise_date: 25% of the shares on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.

SEC source: 0000905718-18-000452 · matinasbiopfm4_apr302018.xml · derivative · entry 1

MANNINO RAPHAEL J · CIK 0001196697 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · Not disclosed shares

Expires 2028-04-29

F1 · derivative.exercise_date: 25% of the shares vest on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.

SEC source: 0000905718-18-000446 · matinasbiop_fm4apr302018.xml · derivative · entry 1

DiPaolo Dominick · CIK 0001704277 · Sr. VP-Quality & Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-04-29

F1 · derivative.exercise_date: 25% of the shares on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.

SEC source: 0000905718-18-000357 · ende_form4mar302018.xml · nonDerivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,760

F1 · shares: On March 30, 2018, the Reporting Person was issued 11,760 shares of common stock par value $.0001 per share which vest immediately upon grant.

SEC source: 0000905718-18-000363 · wiklermatinasfm4_mar302018.xml · nonDerivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,422

F1 · shares: On March 30, 2018, the Reporting Person was issued 18,422 shares of common stock par value $.0001 per share which vest immediately upon grant.

SEC source: 0000905718-18-000359 · conradmatinas_fm4mar302018.xml · nonDerivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,911,179

F1 · shares: On March 30, 2018, the Reporting Person was issued 31,579 shares of common stock par value $.0001 per share which vest immediately upon grant.

SEC source: 0000905718-18-000361 · scibetta_form4mar302018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,981

F1 · shares: On March 30, 2018, the Reporting Person was issued 24,672 shares of common stock par value $.0001 per share which vest immediately upon grant.

SEC source: 0000905718-18-000324 · matinasbiophfm4_mar2218.xml · derivative · entry 1

Jabbour Jerome D · CIK 0001698838 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2028-03-21

F1 · derivative.exercise_date: 25% of the shares vest on March 22, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.

F2 · balance_after: Since the date of the reporting person's last ownership report, he transferred 379,687 shares of issuer's common stock to his ex-wife pursuant to a domestic relations order and he transferred the economic benefits of employee stock options to purchase an aggregate of 612,500 shares with exercise prices ranging from $0.41 to $1.28 per share to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife.

SEC source: 0000905718-18-000033 · wiklermatinasfm4_jan22018.xml · derivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2018-01-01

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on February 2, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000731 · ownership.xml · derivative · entry 1

WIKLER MATTHEW · CIK 0001195414 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-01-01

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on February 2, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-17-001060 · stern_fm4dec272017.xml · nonDerivative · entry 5

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AKS Family Partners LP

Disclosed balance after: 2,939,483

F1 · ownership.nature: Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.

SEC source: 0000905718-17-001060 · stern_fm4dec272017.xml · nonDerivative · entry 4

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AKS Family Foundation, Inc.

Disclosed balance after: 1,750,000

F1 · ownership.nature: Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.

SEC source: 0000905718-18-000281 · ende_fm4dec142017.xml · derivative · entry 1

Ende Eric J · CIK 0001494386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2027-12-13

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on January 14, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-17-000855 · dipaolo_fm4sept282017.xml · derivative · entry 1

DiPaolo Dominick · CIK 0001704277 · Senior VP of Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2027-09-28

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on September 30, 2017. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-17-000833 · mannino_fm4sept112017.xml · nonDerivative · entry 1

MANNINO RAPHAEL J · CIK 0001196697 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,424,565

SEC source: 0000905718-17-000831 · stern_fm4sept72017.xml · nonDerivative · entry 6

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AKS Family Partners LP

Disclosed balance after: 3,689,483

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.39, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.

F1 · ownership.nature: Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.

SEC source: 0000905718-17-000829 · rongen_form4sep82017.xml · nonDerivative · entry 1

Rongen Roelof · CIK 0001698966 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,539,416

SEC source: 0000905718-17-000825 · conrad_fm4sept72017.xml · nonDerivative · entry 1

CONRAD HERBERT J · CIK 0001218815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,879,600

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.40, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0000905718-17-000823 · scibetta_form4sep72017.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418,309

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.37, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0000905718-17-000827 · ferrari_form4sep72017.xml · nonDerivative · entry 1

FERRARI STEFANO · CIK 0001588237 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,984

SEC source: 0000905718-17-000831 · stern_fm4sept72017.xml · nonDerivative · entry 5

STERN ADAM K · CIK 0001403497 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AKS Family Partners LP

Disclosed balance after: 3,639,483

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.

F1 · ownership.nature: Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.

SEC source: 0001019056-17-000603 · lorenzo_4.xml · nonDerivative · entry 2

Lorenzo Jennifer · CIK 0001697285 · Shareholder

GJG Life Sciences, LLC · CIK 0001582638 · Shareholder

GJG Capital, LLC · CIK 0001698996 · Shareholder

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,086,576

F1 · kind: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · price: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · balance_after: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · ownership.direct: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

SEC source: 0001019056-17-000603 · lorenzo_4.xml · nonDerivative · entry 1

Lorenzo Jennifer · CIK 0001697285 · Shareholder

GJG Life Sciences, LLC · CIK 0001582638 · Shareholder

GJG Capital, LLC · CIK 0001698996 · Shareholder

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By GJG Life Sciences, LLC

Disclosed balance after: 0

F1 · kind: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · price: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · balance_after: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · ownership.direct: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.

F1 · ownership.nature: On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC.